10 results
Keyword ipilimumab Remove keyword
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Yervoy (updated)
Date of authorisation: 12/07/2011, Revision: 29, Authorised, Last updated: 13/11/2019Yervoy, INN-ipilimumab 30 Churchill Place … authorisation) Yervoy ipilimumab On 26 April 2018, the Committee … combination of nivolumab with ipilimumab is established only in patients … -
List item
Human medicine European public assessment report (EPAR): Opdivo
Date of authorisation: 19/06/2015,
, Revision: 28, Authorised, Last updated: 28/10/2019
another cancer medicine, ipilimumab, to treat adults whose cancer … used in combination with ipilimumab (another cancer medicine … alone or in combination with ipilimumab. The doctor may need to delay … -
List item
Human medicine European public assessment report (EPAR): Keytruda (updated)
Date of authorisation: 17/07/2015,, Revision: 23, Authorised, Last updated: 20/11/2019
Keytruda or another medicine, ipilimumab. Patients treated with Keytruda … compared with 2.8 months with ipilimumab. Also, up to 74% of patients … compared with 59% of patients on ipilimumab. A third study in 1,019 patients … -
List item
Human medicine European public assessment report (EPAR): Cotellic
Date of authorisation: 20/11/2015,, Revision: 7, Authorised, Last updated: 20/08/2019
-
List item
Human medicine European public assessment report (EPAR): Tafinlar
Date of authorisation: 26/08/2013, Revision: 20, Authorised, Last updated: 26/06/2019 -
List item
Human medicine European public assessment report (EPAR): Mekinist
Date of authorisation: 30/06/2014, Revision: 17, Authorised, Last updated: 26/06/2019 -
List item
Human medicine European public assessment report (EPAR): Tecentriq
Date of authorisation: 20/09/2017,, Revision: 6, Authorised, Last updated: 23/10/2019
-
List item
Human medicine European public assessment report (EPAR): Zelboraf
Date of authorisation: 17/02/2012, Revision: 18, Authorised, Last updated: 23/08/2018 -
List item
Human medicine European public assessment report (EPAR): Yescarta
Date of authorisation: 23/08/2018,, 
, Revision: 2, Authorised, Last updated: 27/05/2019
-
List item
Human medicine European public assessment report (EPAR): Nivolumab BMS
Date of authorisation: 20/07/2015, Withdrawn, Last updated: 14/01/2016